Groups information

Group name

SP

Groups remarks

Match 3

BCR
Continence

Continence

9 (7–10)

p-value

0.02

remark

Median (IQR) postoperative urethral catheterization (Day)

Sexual Function
PSA

PSA

33/38 (86.8%)

p-value

0.73

remark

90-day undetectable PSA rate

Complications or other prognosis

Complications or other prognosis

5/40 (12.5%)

p-value

1

remark

Major complications (CL-D > 3)

Positive surgical margin (PSM)

PSM

15/40 (38.5%)

p-value

0.26

remark

Positive surgical margins

Other quality of life
Surgical related outcomes

Surgical Related Outcomes

12.0 (9.0–12.0)

p-value

0.88

remark

Median lymph node yield (IQR)

Survival Outcome
Survival Outcome
Other outcomes
Follow Up Time

Follow Up Time

90 DAY